A newly approved minimally invasive treatment for congenital heart defects could help up to 8,000 newborns per year, the US Food and Drug Administration announced on 26 March.
The agency approved a PMA for Medtronic’s Harmony transcatheter pulmonary valve (TPV) system in pediatric and adult patients . Harmony...






